Press
Press
-
BioPhy Awarded One of Fast Company’s 2024 World Changing Ideas
Fast Company
-
Every Cure Deploys BioPhy’s Artificial Intelligence Platform to Accelerate its Mission of Repurposing Drugs for Untreated Diseases
Business Wire
-
An in-depth review of the key issues facing Philadelphia's economy, featuring the exclusive insights of prominent business and regional leaders.
Invest: Philadelphia | 5th Anniversary Edition
-
Using AI To Modernize Drug Development And Lessons Learned
Forbes Feature
-
BioPhy Appoints Scott Kobayashi as Senior Vice President of Sales to Accelerate Strategic Expansion
Business Wire
-
AI-driven drug discovery is poised to boom in 2024 | The AI Beat
Venture Beat
-
How industry leaders expect healthcare to change in 2024
Healthcare Brew
-
AbbVie Tries Its Hand at ADCs Again With $10.1B Immunogen Acquisition
MedCityNews
-
These Wharton grads say they can use A.I. to predict the outcomes of drug trials. Chelsea Clinton is among their backers.
The Philadelphia Inquirer
-
Pharma IT and AI – 2024 Health IT Predictions
Healthcare IT Today
-
Chelsea Clinton's VC firm invests in startup that uses AI to accelerate drug development
FOX Business
-
The company's operating system accelerates the ID and development of promising drug candidates
Vator News
-
MedCity News
How Are AI Companies Reacting to HHS’ New Transparency Requirements?
-
Philadelphia-based Startup, BioPhy, Uses Breakthrough AI Technology to Help Accelerate the Drug Trial Process
Philadelphia Today
-
BioPhy: $4.5 Million Raised To Use AI For Accelerating The Development Of Promising Drug Candidates
Pulse 2.0
-
Many open questions remain on AI risks, liability that will likely play out in court, experts say
Fierce Healthcare
-
BioPhy launches AI platform to accelerate drug development with $4.5M investment led by Chelsea Clinton's VC firm
The Philadelphia Business Journal
-
Endpoints Healthtech Roundup
Endpoints
-
AI dominates Milken Summit onstage and off
POLITICO
-
Health Tech
Axios Pro Health Tech Deals
-
Philadelphia-based Startup, BioPhy, Uses Breakthrough AI Technology to Help Accelerate the Drug Trial Process
Montco.Today
-
Two Wharton graduates create AI startup that predicts drug trial outcomes
The Daily Pennsylvania
-
5 Things About AI You May Have Missed Today
HT Tech
-
Fundings
Strictly VC
-
AI Predictions for Colombian League's Final Matches and Its Impact on Drug Development
BNN Breaking
-
BioPhy Raises $4.5M in Funding
FinSMEs
-
The Part of the Deal
Axios Pro Rata
-
Backed by $4.5M raise, BioPhy is using AI to predict successful clinical trials
Technical.ly
-
Exclusive: Clinical trial company bags $4.5M pre-seed
Axios
-
What does Biden’s executive order to regulate AI mean for healthcare?
MM+M
-
BioPhy Launches Breakthrough AI Platform to Accelerate the Trillion Dollar Drug Development Market
Business Wire